SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001999371-24-004802
Filing Date
2024-04-15
Accepted
2024-04-15 16:38:51
Documents
7
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tonix-def14a_042224.htm DEF 14A 495534
2 GRAPHIC tonix-pre14a_img001.jpg GRAPHIC 49544
3 GRAPHIC tonix-pre14a_img002.jpg GRAPHIC 48412
4 GRAPHIC proxycard001.jpg GRAPHIC 1141
5 GRAPHIC proxycard002.jpg GRAPHIC 4152
6 GRAPHIC proxycard003.jpg GRAPHIC 2954
7 GRAPHIC proxycard004.jpg GRAPHIC 4259
  Complete submission text file 0001999371-24-004802.txt   649683
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36019 | Film No.: 24845139
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)